After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, SPRY falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of ARS Pharmaceuticals Inc is $1.02B. A total of 3.05 million shares were traded on the day, compared to an average of 2.30M shares.
In the most recent transaction, Lowenthal Richard E sold 50,000 shares of SPRY for 14.49 per share on Aug 21 ’25. After the transaction, the PRESIDENT AND CEO now owns 1,196,494 company shares. In a previous transaction on Aug 21 ’25, Scott Kathleen D. sold 12,500 shares at 15.00 per share. SPRY shares that Chief Financial Officer owns now total 10,042.
Among the insiders who sold shares, Tanimoto Sarina disposed of 37,656 shares on Aug 20 ’25 at a per-share price of $14.09. This resulted in the CHIEF MEDICAL OFFICER holding 1,247,447 shares of SPRY after the transaction. In another insider transaction, Tanimoto Sarina sold 12,344 shares at $14.03 per share on Aug 19 ’25. Company shares held by the CHIEF MEDICAL OFFICER now total 1,285,103.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, SPRY has a high of $18.90 and a low of $9.34.
As of this writing, SPRY has an earnings estimate of -$0.49 per share for the current quarter. EPS was calculated based on a consensus of 5.0 estimates, with a high estimate of -$0.46 per share and a lower estimate of -$0.56. The company reported an EPS of -$0.2 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. SPRY’s latest balance sheet shows that the firm has $60.06M in Cash & Short Term Investments as of fiscal 2021. There were $9.03M in debt and $8.19M in liabilities at the time. Its Book Value Per Share was $1.95, while its Total Shareholder’s Equity was -$31.27M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SPRY is Buy with a score of 4.71.
